|Date||June 11 - June 15|
|Venue||The Grand Hotel Malahide|
Malahide, K36XT65 Ireland
+ Google Map
This FASEB Science Research Conference (SRC) focuses on the cellular and biophysical mechanisms, structures, and (patho)physiological consequences of protein aggregation.
Launched in 1995, this conference continues to serve as a forum for sharing primarily unpublished findings from different academic labs and discussing new and emerging themes in protein aggregation. This includes traditional core themes of the meeting series such as the structure of aggregates, the mechanisms of aggregate assembly, and the mechanisms of proteotoxicity.
The conference brings together a diverse group of primarily academic scientists studying protein aggregation and aims to maximize opportunities for participants to communicate their research, especially first-time attendees, early-career scientists, and those from traditionally underrepresented backgrounds.
The program is designed to provide a safe space for participants to discuss and share ideas and to deliver career development, networking, and training opportunities to the next generation of protein aggregation scientists.
Program sessions will present the latest findings and foster discussion on:
- Structure, Aggregation Kinetics
- Liquid-Liquid Phase Separation
- Functional Aggregation
- Disease and Therapeutics
- Aggregation Mechanisms In Vitro
- Emerging Experimental Technologies
- Emerging Computational Technologies
The conference covers nine sessions with 27 presentations selected from abstracts. “Meet the Expert” sessions will provide informal round-table discussions over lunch between early-career scientists and the speakers of the preceding session.
Also included is a Career Development Workshop structured as a panel discussion of established researchers in a Q&A format. Questions will be solicited from the audience and moderated by two post-doctoral chairs.
Keynote Speaker: Hilal Lashuel, PhD, Associate Professor of Neuroscience and Director of the Laboratory of Molecular and Chemical Biology of Neurodegeneration, Brain Mind Institute, Swiss Federal Institute of Technology Lausanne (EPFL)